Table 1.
No. and Percent of cases |
No. and Percent of controlsa |
Quartile Median |
Odds Ratio |
95% Confidence Interval |
Ptrend | |||
---|---|---|---|---|---|---|---|---|
Body Mass Index (kg/m2) | N | % | N | % | ||||
17.8 to 24.0 | 28 | 18 | 87 | 28 | 22.8 | Reference | ||
24.1 to 26.2 | 38 | 25 | 77 | 25 | 25.2 | 1.5 | 0.9, 28 | |
26.3 to 28.3 | 43 | 28 | 73 | 24 | 27.2 | 1.8 | 1.0, 3.3 | |
28.4 to 40.7 | 45 | 29 | 71 | 23 | 30.5 | 1.9 | 1.1, 3.2 | 0.022 |
Systolic Blood Pressure (mmHg) | ||||||||
100–129 | <5 | 3 | 17 | 6 | N/A | Reference | ||
130–139 | 42 | 27 | 102 | 33 | N/A | 2.8 | 1.5, 5. | |
140–153 | 65 | 42 | 121 | 39 | N/A | 2.3 | 1.3, 4.3 | |
154–226 | 43 | 28 | 68 | 22 | N/A | 2.7 | 1.4, 5.1 | 0.014 |
Dietary Calcium (mg/d) | ||||||||
206.4 to 1019.3 | 40 | 26 | 75 | 24 | 773.2 | Reference | ||
1019.4 to 1313.4 | 34 | 22 | 82 | 27 | 1150.6 | 0.8 | 0.4, 1.4 | |
1313.5 to 1668.7 | 43 | 28 | 72 | 23 | 1479.6 | 1.1 | 0.7, 1.9 | |
1668.8 to 3854.2 | 37 | 24 | 79 | 26 | 1932.9 | 0.9 | 0.5, 1.5 | 0.756 |
Dietary Vitamin D (ug/d) | ||||||||
0.7 to 3.4 | 77 | 50 | 39 | 13 | 2.6 | Reference | ||
3.5 to 4.8 | 78 | 51 | 37 | 12 | 4.3 | 0.9 | 0.5, 1.6 | |
4.9 to 7.1 | 82 | 53 | 33 | 11 | 6 | 0.8 | 0.5, 1.4 | |
7.2 to 17.6 | 71 | 46 | 45 | 15 | 9.1 | 1.3 | 0.7, 2.2 | 0.507 |
Alcoholic Beverage Intake (g/d) | ||||||||
0 to 23.3 | 45 | 29 | 70 | 23 | 0 | Reference | ||
23.4 to 88.0 | 36 | 23 | 81 | 26 | 58.1 | 0.7 | 0.4, 1.2 | |
88.1 to 214.2 | 42 | 27 | 68 | 22 | 133.1 | 1.0 | 0.6, 1.6 | |
214.3 to 2009.0 | 31 | 20 | 90 | 29 | 425.6 | 0.5 | 0.3, 0.9 | 0.124 |
High Risk Occupational Groupb | ||||||||
Yes | 25 | 16 | 54 | 18 | 1 | 0.9 | 0.6, 1.5 | |
No | 129 | 84 | 254 | 82 | 0 | Reference | 0.360 | |
Serum calcium concentration (mg/dL) | ||||||||
6.8 to 9.4 | 46 | 30 | 69 | 22 | 9.2 | Reference | ||
9.5 to 9.9 | 44 | 29 | 67 | 22 | 9.7 | 1.0 | 0.6, 1.7 | |
10.0 to 10.2 | 29 | 19 | 53 | 17 | 10.1 | 0.8 | 0.5, 1.5 | |
10.3 to 14.0 | 35 | 23 | 119 | 39 | 10.6 | 0.4 | 0.3, 0.8 | <0.001 |
Serum 25-OH vitamin D (ng/mL)c | ||||||||
0.2 to 8.5 | 34 | 23 | 36 | 27 | 6.1 | Reference | ||
8.6 to 13.0 | 36 | 25 | 33 | 25 | 10.7 | 1.2 | 0.6, 2.3 | |
13.1 to 18.6 | 40 | 28 | 30 | 23 | 16.2 | 1.4 | 0.7, 2.8 | |
18.7 to 36.7 | 35 | 24 | 34 | 26 | 22.6 | 1.2 | 0.6, 2.5 | 0.475 |
Blood lead concentration (µg/dL) | ||||||||
0.6 to 2.4 | 27 | 20 | 81 | 27 | 2.0 | Reference | ||
2.5 to 3.2 | 31 | 23 | 81 | 27 | 2.9 | 1.1 | 0.6, 2.1 | |
3.3 to 4.6 | 40 | 29 | 70 | 23 | 3.9 | 1.7 | 0.9, 3.2 | |
4.7 to 15.2 | 38 | 28 | 72 | 24 | 5.8 | 1.7 | 0.9, 3.1 | 0.240 |
Cases and controls were matched on age at randomization, serum and whole blood draw dates, pack-years, ATBC treatment group, and follow-up time.
Occupations include: mining, colliery (coal mining), quarrying, stonemasonry, stonecutting, foundry work, asbestos quarrying, asbestos fabric manufacture, asbestos concrete manufacture, asbestos insulating, lead refining, nickel refining, copper smelting, steel production/ refining, oil refining, gas manufacture, chromium paint manufacture, and arsenic production. P-trend based on the total number of high risk occupations.
Only one set of controls had vitamin D serum measurements.